Monte Rosa Therapeutics, Inc. (GLUE) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $215.60M | -0.1% |
| 2024 | $215.80M | +73.3% |
| 2023 | $124.50M | +75.4% |
| 2022 | $70.98M | +277.3% |
| 2021 | $18.81M | -38.0% |
| 2020 | $30.34M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $215.60M | -0.1% |
| 2024 | $215.80M | +73.3% |
| 2023 | $124.50M | +75.4% |
| 2022 | $70.98M | +277.3% |
| 2021 | $18.81M | -38.0% |
| 2020 | $30.34M | — |